137 related articles for article (PubMed ID: 9661001)
21. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Chono K; Katsumata K; Suzuki H; Shiraki K
Antiviral Res; 2013 Feb; 97(2):154-60. PubMed ID: 23261844
[TBL] [Abstract][Full Text] [Related]
22. In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2.
Weinberg A; Bate BJ; Masters HB; Schneider SA; Clark JC; Wren CG; Allaman JA; Levin MJ
Antimicrob Agents Chemother; 1992 Sep; 36(9):2037-8. PubMed ID: 1329640
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological activity of tricyclic analogues of 9-[[cis-1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine.
Ostrowski T; Golankiewicz B; De Clercq E; Balzarini J
Bioorg Med Chem; 2006 May; 14(10):3535-42. PubMed ID: 16458009
[TBL] [Abstract][Full Text] [Related]
24. Comparative activity of various compounds against clinical strains of herpes simplex virus.
Andrei G; Snoeck R; Goubau P; Desmyter J; De Clercq E
Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):143-51. PubMed ID: 1327785
[TBL] [Abstract][Full Text] [Related]
25. Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.
Sutton D; Boyd MR
Antimicrob Agents Chemother; 1993 Apr; 37(4):642-5. PubMed ID: 8388195
[TBL] [Abstract][Full Text] [Related]
26. Analysis of phosphorylation pathways of antiherpesvirus nucleosides by varicella-zoster virus-specific enzymes.
Koyano S; Suzutani T; Yoshida I; Azuma M
Antimicrob Agents Chemother; 1996 Apr; 40(4):920-3. PubMed ID: 8849252
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).
Shiraki K; Miyaki C; Namazue J; Yamanishi K; Takahashi M
Acta Virol; 1989 Dec; 33(6):565-8. PubMed ID: 2576598
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. II.
Maruyama T; Hanai Y; Sato Y; Snoeck R; Andrei G; Hosoya M; Balzarini J; De Clercq E
Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):516-21. PubMed ID: 8386594
[TBL] [Abstract][Full Text] [Related]
29. Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy.
Hasegawa Y; Nishiyama Y; Imaizumi K; Ono N; Kinoshita T; Hatano S; Saito H; Shimokata K
Cancer Gene Ther; 2000 Apr; 7(4):557-62. PubMed ID: 10811473
[TBL] [Abstract][Full Text] [Related]
30. Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine.
Ng TI; Shi Y; Huffaker HJ; Kati W; Liu Y; Chen CM; Lin Z; Maring C; Kohlbrenner WE; Molla A
Antimicrob Agents Chemother; 2001 Jun; 45(6):1629-36. PubMed ID: 11353604
[TBL] [Abstract][Full Text] [Related]
31. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
32. Comparison of susceptibilities of varicella-zoster virus and herpes simplex viruses to nucleoside analogs.
Machida H
Antimicrob Agents Chemother; 1986 Mar; 29(3):524-6. PubMed ID: 3013088
[TBL] [Abstract][Full Text] [Related]
33. In vitro susceptibility of varicella-zoster virus to acyclovir.
Biron KK; Elion GB
Antimicrob Agents Chemother; 1980 Sep; 18(3):443-7. PubMed ID: 6252836
[TBL] [Abstract][Full Text] [Related]
34. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.
Field AK; Davies ME; DeWitt C; Perry HC; Liou R; Germershausen J; Karkas JD; Ashton WT; Johnston DB; Tolman RL
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4139-43. PubMed ID: 6306664
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.
Gephart JF; Lerner AM
Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244
[TBL] [Abstract][Full Text] [Related]
36. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
[TBL] [Abstract][Full Text] [Related]
37. Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus.
Biron KK; Fyfe JA; Noblin JE; Elion GB
Am J Med; 1982 Jul; 73(1A):383-6. PubMed ID: 6285728
[TBL] [Abstract][Full Text] [Related]
38. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
Yang L; Mo X; Yang H; Dai H; Tan F
J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
[TBL] [Abstract][Full Text] [Related]
39. [Synthesis of adenine derivatives and their activities against herpes virus in vitro].
Zhong M; Liu ZP; Xu LJ; Wang ZY; Wang GT
Yao Xue Xue Bao; 1996; 31(11):837-43. PubMed ID: 9863254
[TBL] [Abstract][Full Text] [Related]
40. The effect of gramicidin, a topical contraceptive and antimicrobial agent with anti-HIV activity, against herpes simplex viruses type 1 and 2 in vitro.
Bourinbaiar AS; Coleman CF
Arch Virol; 1997; 142(11):2225-35. PubMed ID: 9672588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
